Crane Company (CR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Executive summary
Achieved record financial and operational results in 2025, with 13% sales growth in Aerospace & Advanced Technologies and 5% in Process Flow Technologies, driven by organic growth, acquisitions, and portfolio transformation.
Completed major acquisitions, including Panametrics, Druck, and Reuter-Stokes for $1.06 billion, and optek-Danulat, enhancing capabilities in both core segments.
Divested Engineered Materials segment to focus on two strategic growth platforms.
Increased combined equity value by approximately $9 billion since 2022, a 157% rise.
Voting matters and shareholder proposals
Stockholders will vote on: (1) election of nine directors for one-year terms, (2) ratification of Deloitte & Touche LLP as independent auditors for 2026, and (3) a non-binding advisory vote on executive compensation.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of nine members, eight of whom are independent; will expand to ten with incoming CEO Alcala.
Board rejected resignation of Lead Independent Director Tullis, citing his value during CEO transition.
Board committees (Audit, Compensation, Nominating/Governance) are 100% independent.
Annual board and committee self-evaluations, director retirement and overboarding policies, and majority voting with resignation policy in place.
CEO succession plan executed: Alcala to become CEO after Annual Meeting, Mitchell to transition to Executive Chairman.
Latest events from Crane Company
- Record Q2 sales, margin expansion, and raised EPS guidance driven by strong demand and acquisitions.CR
Q2 2026 - Record adjusted EPS and 24.9% sales growth drove raised full-year guidance and strong M&A capacity.CR
Q1 2026 - Proxy details director elections, auditor ratification, and strong 2024 performance with robust governance.CR
Proxy filing - Annual meeting to vote on directors, auditor, and pay, with online and eco-friendly options.CR
Proxy filing - Record 2025 EPS growth, robust M&A, and 10% EPS growth guidance for 2026.CR
Q4 2025 - Adjusted EPS up 27% on strong sales; guidance raised and PSI acquisition progressing.CR
Q3 2025 - Q2 sales up 9.2%, EPS up 24%, guidance raised, and $1.06–$1.15B PSI acquisition announced.CR
Q2 2025 - Q1 2025 delivered strong EPS and sales growth, with robust outlook and active M&A pipeline.CR
Q1 2025 - Q4 adjusted EPS up 58%, 2025 guidance raised, and dividend increased 12%.CR
Q4 2024